Vaccine Quick Facts

Hepatitis B

Key facts about Hepatitis B disease and the Hepatitis B vaccine to support your informed vaccination decision.

What Is Hepatitis B?

  • Hepatitis B (HBV) is a virus that affects the liver and spreads through direct contact with infected blood or certain body fluids.
  • Most hepatitis B infections cause no symptoms, but when symptoms do occur, they usually appear about 90 days after exposure, last several weeks, and may include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, pale (clay-colored) stools, joint pain, and jaundice (yellowing of the skin or eyes).
  • People at higher risk for complications or chronic hepatitis B include older adults, individuals with weakened immune systems or underlying medical conditions, pregnant women, infants infected at birth, and people receiving hemodialysis.
  • Most adults with acute hepatitis B have mild or no symptoms and require only rest and supportive care. About 95% recover fully with lifelong immunity, while severe complications such as liver failure are rare. Fewer than five percent of adults develop chronic hepatitis B infection, but infants and children are more likely to develop chronic hepatitis B and be at high risk for developing serious liver disease later in life.
  • In 2023, there were 2,214 new cases of acute hepatitis B, 17,650 newly reported chronic cases, and 1,769 hepatitis B–related deaths.

The Hepatitis B Vaccine

  • The hepatitis B vaccine is a recombinant injectable vaccine that today is administered in the U.S. either as a single-dose shot, or in combination with other antigens, including hepatitis A, diphtheria, tetanus, acellular pertussis, Hib, and inactivated poliovirus.
  • The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends shared clinical decision-making for infants born to mothers who test negative for hepatitis B. This means that parents and health care providers should review the vaccine’s benefits and risks, along with the child’s risk for hepatitis B infection, and together decide if and when to begin the hepatitis B vaccination series.
  • ACIP recommends the first dose be given at two months to an infant born to a hepatitis B negative mother if the at-birth dose is skipped. The committee also advises parents to consult with their provider about testing for hepatitis B antibody titers to help determine whether additional doses of the vaccine are appropriate.
  • The current recommendation replaces the 1991 ACIP guidance that previously called for hepatitis B vaccination of all newborns, regardless of whether the mother was hepatitis B negative. This previous guidance was adopted after efforts to vaccinate adults at high risk for being infected with hepatitis B — primarily IV drug users and individuals with multiple sexual partners — was largely unsuccessful.
  • Even if you get hepatitis B shots, you can still get hepatitis B depending upon your genetics, age and variables such as encountering a rare strain of the virus.
  • There are seven hepatitis B vaccines available in the U.S., ranging from single-dose vaccines to combination vaccines with up to five other antigens.
  • Recombinant Hepatitis B Vaccine Product Insert and Licensing Information
  • Adjuvanted Recombinant Hepatitis B Vaccine Product Insert and Licensing Information
  • Hepatitis B Vaccine (Recombinant) – PREHEVBRIO — Vaccine Product Insert and Licensing Information
  • Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined — Product Insert and Licensing Information
  • Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine Product Insert and Licensing Information
  • Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine — Vaccine Product Insert and Licensing Information

Natural Immunity vs. Vaccine Immunity

  • Adults who clear a hepatitis B infection usually gain lifelong immunity, but when it is contracted in infancy or childhood, it can become a chronic, lifelong infection. Transmission during infancy in the U.S. occurs almost exclusively from mother to newborn during childbirth and only when the mother is hepatitis B positive.
  • Unlike in the U.S. where hepatitis B infections have never been prevalent, in other areas of the world where hepatitis B is endemic and a larger proportion of the population has been or is infected, there is more transmission between individuals during childhood. However, childhood transmission in the U.S. is rare.
  • The CDC estimates that over 90% of people develop antibodies after completing the three-dose hepatitis B vaccine series, but the duration of protection and the need for future booster shots remain unclear, and boosters are not currently recommended. Studies show that only about 16% of those vaccinated in infancy still have detectable antibodies after 18 years, compared with about 74% of those vaccinated after age one.
  • Hepatitis B breakthrough infections can occur in vaccinated people who fail to develop an immune response (non-responders) or are exposed to rare mutated strains of the virus. Public health officials maintain these cases are often linked to factors like genetics, age, or specific lifestyle habits.
  • Hepatitis B cases in the U.S. fell 59% between 1985 and 1993, largely due to behavior changes by individuals at high risk during the AIDS epidemic rather than the 1991 infant vaccination recommendation. Rates were already declining before the first dose of hepatitis B vaccine began to be given to every infant on the first day after birth in hospital newborn nurseries.
  • Reported cases of hepatitis B infections in the U.S. have remained stable since 2020 at about 0.7 cases per 100,000 people.

Vaccine Risks & Adverse Events

  • According to hepatitis B vaccine package inserts, common side effects include redness, warmth, or swelling at the injection site and fever over 99.9°F, which may last one to two days. Reported systemic reactions include irritability, diarrhea, fatigue, weakness, decreased appetite, and rhinitis.
  • More serious adverse events have also been reported to the Vaccine Adverse Events Reporting System (VAERS) and in medical literature, including autoimmune, neurological, metabolic, vascular, and blood disorders. These and other serious hepatitis B vaccine reactions are documented in the medical literature and in reports to VAERS to occur following receipt of hepatitis B vaccine.
  • Hepatitis B vaccine injuries have been compensated by the U.S. government under the Vaccine Injury Compensation Program (VICP) created by the National Childhood Vaccine Injury Act of 1986.

Individual Susceptibility

The Institute of Medicine, National Academy of Sciences, has acknowledged in published reports that:

  • Individuals vary in susceptibility to vaccine reactions due to differences in biological, genetic, epigenetic and environmental factors.
  • Doctors and other medical workers administering vaccines often do not know how to predict who will be harmed before vaccination due to gaps in scientific knowledge about who is genetically or otherwise biologically at high risk for suffering harm.
  • A previous vaccine reaction can raise the risks for a reaction after another dose of vaccine.
  • It is very important to consider your health or your child’s health and review your own and your family’s health history for the presence of autoimmune, allergic, neurological and metabolic disorders when making a decision about the timing of vaccination or whether or not to vaccinate.

Nobody can guarantee in advance that your child will not be injured by a vaccine or an infectious disease. NVIC supports your legal right to have full information about the risks of a disease and the risks of a vaccine and the freedom to exercise voluntary, informed consent to vaccination without being coerced or sanctioned for the decision made.

NVIC supports the ending of vaccine mandates in every state.

Key Takeaways

  • Hepatitis B is most dangerous in infants and young children because they have a higher risk of developing a lifelong chronic infection, which can lead to serious health issues later in life.
  • Documented hepatitis B vaccine complications exist and can include autoimmune, neurological, metabolic, and vascular conditions.
  • The U.S. government has awarded compensation to children and adults injured by hepatitis B containing vaccines.
  • Hepatitis B vaccine acquired immunity wanes and long-term effectiveness is not well established.
  • While acute hepatitis B infections typically provide lifelong immunity, a small percentage of individuals—particularly infants and young children—develop chronic infections that can lead to serious health issues.
  • You have the right to know and should have the freedom to choose whether or not to accept a vaccine risk for your child without being sanctioned for the choice you make.

Bottom Line

Vaccination is not a one-size-fits-all medical intervention. Before you take a risk, find out what it is.

Search for Vaccine Reactions

NVIC hosts MedAlerts, a powerful and user-friendly search engine of the federal Vaccine Adverse Events Reporting System (VAERS). MedAlerts makes it easy to search for vaccine reaction reports to VAERS, including immediate symptoms and long term adverse health outcomes, dates and places the vaccines were administered, ER visits, hospitalizations and more.

Search MedAlerts (VAERS) →

IMPORTANT NOTE: NVIC encourages you to become fully informed about Hepatitis B and the Hepatitis B vaccines, including reviewing the References at the end of this page and reading all sections in the Table of Contents. You will find many useful links and resources with more detailed information, such as the manufacturer product information inserts, that help you make a decision about vaccination. You are also encouraged to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information provided by NVIC is for educational purposes only and is not intended as medical advice.